SR-9009 Stenabolic Capsules

SR-9009 Stenabolic Capsules

Uncover the potential of SR-9009 Stenabolic Capsules, a versatile research compound available through BehemothLabz for laboratory research. SR-9009, also called Stenabolic, is a synthetic REV-ERB agonist designed to impact metabolic functions and circadian rhythms potentially. 

BehemothLabz offers SR-9009 Stenabolic Capsules and liquid variants tailored for research, ensuring consistent and dependable outcomes. Please note these products are exclusively for laboratory research and unsuitable for human consumption.

SR-9009 Stenabolic Capsules Product Details

• CAS Number is stated as 1379686-30-2
• Molar Mass is 437.94026 g·mol−1
• It has a Chemical Formula of C20H24ClN3O4S
• IUPAC Name is ethyl-3-(((4-chlorobenzyl)((5-nitrothiophen-2-yl)methyl)amino)methyl)pyrrolidine-1-carboxylate

The Stenabolic (SR-9009) capsules available to buy from BehemothLabz are intended for laboratory research use only and not for human consumption.

We also offer Stenabolic in liquid form if you are interested in those instead. 

What is the SR-9009 Stenabolic Capsule? 

SR9009 is a synthetic REV-ERB agonist. REV-ERBs are proteins that regulate the circadian rhythm, or the body’s internal 24-hour clock. Circadian rhythms, in turn, control various body functions, including sleep-wake cycles, fat burning and storage, and body temperature. [R][R]

SR9009 was initially discovered in 2012 at Scripps Research Institute. In one of its first studies, SR9009 demonstrated the potential to stimulate significant fat loss and reduce body weight. Mice injected with Stenabolic for a week lost weight due to reduced fat mass. [R]

Stenabolic protects heart health in various ways. Besides reducing the size of atherosclerotic plaque in blood vessels, SR9009 reduced blood levels of total cholesterol and triglycerides in mice models. High levels of cholesterol and triglyceride are harmful to the heart. [R][R]

Recent research has explored SR9009’s anti-cancer effects. A pre-clinical study has found that it potentially inhibits chemo-sensitive and chemo-resistant small lung cancer cells. Another study has shown that Stenabolic may potentially exert a cytotoxic effect on different types of cancer cells. [R][R]

Potential Applications of SR-9009 Stenabolic Capsules

Stenabolic SR-9009 and Weight Loss

In a study involving three groups of mice models, SR9009 was administered to subjects with average body weight. Over seven days, the normal-weight mice experienced notable weight loss. Researchers determined that this weight reduction was mainly due to decreased fat mass, indicating that SR9009 targets and diminishes adipose tissue. This effect is likely because SR9009 potentially enhances metabolic activity and boosts energy expenditure, leading to the observed reduction in fat mass.  [R]

The second group in the study consisted of mice models with diet-induced obesity. These mice received SR9009 for 30 days, and the results were striking. The treated mice lost 60% more weight than those in the control group. This significant decrease in body weight highlights SR9009’s potential as a treatment for obesity. By potentially boosting mitochondrial biogenesis and increasing metabolic rate, SR9009 facilitates the conversion of stored fat into energy, resulting in notable weight loss in obese mice models. [R]

The third group comprised genetically obese mice, a model that closely mimics certain human conditions of obesity. In this group, SR9009 treatment for 12 days resulted in the cessation of weight gain. This finding is particularly notable as it suggests that SR9009 may stabilize body weight even with genetic predispositions to obesity. The cessation of weight gain indicates SR9009’s potential role in regulating metabolic processes and maintaining energy balance in genetically obese subjects. [R]

Stenabolic SR-9009 and Heart Health

Studies on mice models have shown that administering SR9009 for 7 to 10 days significantly lowered triglyceride and total cholesterol levels. Another study observed that SR9009 reduced total cholesterol, triglycerides, and LDL cholesterol in mice models fed a high-cholesterol diet. These results suggest that SR9009 might be crucial in managing lipid levels, which may improve heart health by reducing the risk of atherosclerosis and other cardiovascular diseases. [R][R]

In a different study involving genetically modified mice models susceptible to atherosclerosis, seven weeks of SR9009 treatment significantly reduced blood vessel lesion size. This reduction occurred without altering food intake, indicating that the cardiovascular benefits of SR9009 are not tied to dietary changes. By minimizing lesion size, SR9009 may help prevent the progression of arterial hardening, a significant contributor to heart disease. [R]

SR9009 also shows the potential to improve heart structure and function. In mice models with surgically induced heart enlargement, a 14-day course of Stenabolic treatment reduced both heart size and weight. The same study found that four weeks of SR9009 administration potentially improved heart function in both standard and genetically modified older mice models. These improvements suggest that SR9009 might be beneficial in treating heart hypertrophy conditions and maintaining cardiac function as organisms age. [R]

Stenabolic SR-9009 and Inflammation

A significant study on mice models has demonstrated SR9009’s potential anti-inflammatory properties, especially in endotoxin-induced inflammation. The research indicated that activating REV-ERBα with SR9009 considerably reduced lipopolysaccharide (LPS)-induced inflammation in both cell cultures and live animal models. This finding suggests that SR9009 may effectively mitigate the inflammatory response caused by endotoxins, which are elements of some bacterial cell walls that may lead to intense inflammatory reactions. [R]

Stenabolic SR-9009 and Cancer

SR9009, known as Stenabolic, has shown encouraging potential in fighting cancer, as evidenced by recent cell culture studies. These findings indicate that SR9009 might be a valuable therapeutic option for treating small-cell lung cancer (SCLC), impacting chemo-sensitive and chemo-resistant SCLC cells. This positions SR9009 as a potential addition to current treatment strategies, offering hope for test subjects who may not respond well to traditional chemotherapy. [R]

In addition to its efficacy against SCLC, SR9009 has demonstrated cytotoxic effects on cancer cells from diverse tumor types, including brain, leukemia, breast, colon, and melanoma. This broad-spectrum activity mirrors SR9011, another REV-ERB agonist known for its similar anti-tumor properties. These findings highlight SR9009’s potential as a versatile agent in the fight against various cancers. [R]

Stenabolic SR-9009 and Wakefulness

Research involving mice models has demonstrated that those injected with SR9009 during the daytime exhibited increased activity levels and reduced sleep. This suggests that SR9009 may effectively promote wakefulness, making it a potential candidate for managing sleep-related disorders or enhancing daytime alertness. The ability to increase activity and reduce sleep without losing efficacy over time makes SR9009 a noteworthy compound for further exploration. [R]

One of the significant advantages of SR9009 is that it maintains its effectiveness even when administered multiple times a day. Studies have shown that mice models do not develop tolerance to SR9009, indicating that its potential wakefulness-promoting effects are sustained with regular use. This consistency in efficacy is crucial for any potential therapeutic application, ensuring reliable and predictable outcomes. [R]

Through a time response paradigm, researchers have identified an optimal time for administering SR9009 to achieve maximal efficacy. The studies indicate a specific 12-hour window during which SR9009 elicits its wakefulness-enhancing response. Understanding this timing is essential for optimizing the use of SR9009 in clinical settings, ensuring that its administration aligns with the desired wakefulness and activity patterns. [R]

How do SR-9009 Stenabolic Capsules Work? 

SR-9009, also known as Stenabolic, is a synthetic REV-ERB agonist that shows potential for enhancing wakefulness, supporting weight loss, and improving cardiovascular health. It works by potentially activating the REV-ERBα and REV-ERBβ nuclear receptors, which play a crucial role in regulating genes involved in metabolism. When SR-9009 binds to these receptors, it potentially helps regulate the circadian rhythm, which affects sleep-wake cycles and metabolic functions. Additionally, SR-9009 influences lipid and glucose metabolism by potentially reducing fat storage and increasing fat burning, aiding in weight management and metabolic health. The compound also has anti-inflammatory properties, potentially reducing the production of pro-inflammatory cytokines and increasing anti-inflammatory gene expression. Furthermore, SR-9009 boosts mitochondrial function, potentially enhancing energy expenditure and physical endurance, which benefits weight loss and athletic performance. It also promotes the burning of fats while preserving muscle mass, helping to potentially reduce fat and maintain muscle. 

Safety and Side Effects

While SR9009, also known as Stenabolic, shows potential benefits for wakefulness, weight management, and cardiovascular health, it’s essential to be aware of its possible side effects and safety considerations. The critical monitoring areas include liver health, hormonal balance, sleep patterns, and digestive comfort. Due to humans’ lack of long-term data, using SR9009 cautiously and under medical supervision is advisable. Following recommended dosages, being mindful of possible interactions, and sourcing high-quality products may help reduce the risks of using SR9009.

Note: For further research and support, consider checking out our comprehensive range of SARM Support products, designed to complement your SR-9009 research. Additionally, you can explore Silymarin 98% + TUDCA Capsules for liver health support, or dive into our SR-9009 Liquid if you prefer an alternative form. Enhance your research journey with the right tools and resources!

Frequently Asked Questions 

What is SR9009 used for? 

SR9009 (Stenabolic) is used to potentially enhance wakefulness, support weight loss, improve cardiovascular health, reduce inflammation, boost physical performance, and potentially offer anti-cancer benefits. Its multifaceted effects make it a versatile compound for various health applications. 

SR9009, how long will it take to see results? 

Most test subjects start to see some benefits of SR9009 within a few days to a few weeks, with more significant changes in areas like weight management, physical performance, and cardiovascular health becoming evident over a more extended period. Consistent use combined with a healthy lifestyle is recommended for the best results.

Is SR9009 safe? 

The safety of SR9009 (Stenabolic) is still under investigation, as it has primarily been studied in animal models and not extensively tested in humans. While preliminary research shows potential benefits for wakefulness, weight management, and cardiovascular health, possible side effects such as liver enzyme alterations and hormonal disruptions warrant caution. Additionally, the lack of long-term human data means that the complete safety profile of SR9009 still needs to be established. Therefore, using SR9009 cautiously and under medical supervision, adhering to recommended dosages, and ensuring high-quality sourcing to mitigate potential risks is advisable.

Why Buy SR-9009 Stenabolic Capsules from BehemothLabz?

BehemothLabz is the best place to purchase SR-9009 Stenabolic Capsules.

We have been around since 2014, supplying the highest-quality research compounds money can buy. Our products come with a 100% satisfaction guarantee, free and fast shipping, and a money-back guarantee on SR-9009 Stenabolic Capsules.

Summary

SR-9009, also known as Stenabolic, is a multifaceted research compound demonstrating potential in weight management, cardiovascular health, and inflammation regulation. As a synthetic REV-ERB agonist, it affects metabolic processes and circadian rhythms, potentially supporting fat loss, cardiovascular improvement, wakefulness enhancement, and anti-cancer effects. It’s crucial to note that SR-9009 is strictly for laboratory research and should not be used for human consumption.

BEHEMOTHLABZ DISCLAIMER

Please make sure you go through the Terms and Conditions and familiarize yourself with them, as they are important. Please research the scientific uses of this product before making any purchases. Make note that the packaging and labels of the product may differ from those shown on the website.

Buying the product means you agree to our Terms and Conditions. If you are not fully satisfied with the product, you can contact our awesome customer service team at  support@behemothlabz.com.

Customer satisfaction is our number one priority!

All BehemothLabz products are strictly for LABORATORY AND RESEARCH PURPOSES ONLY. They are not to be used for any human or veterinary purposes.

Variant	20mg/30ct/600mg, 20mg/60ct/1.2grams

1st Party COA

3rd Party COA